Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Ketamine Infusion for Acute Sickle Cell crisiS in the Emergency Department

To see complete record on, please visit this link

Id: NCT02417298

Organisation Name: The Brooklyn Hospital Center

Overal Status: Terminated

Start Date: November 2015

Last Update: May 11, 2018

Lead Sponsor: Billy Sin

Brief Summary: Pain associated with sickle cell disease is a common emergency department visit. It is also frequently associated with a high emergency department recidivism rate for pain control and admissions to the hospital. Opiates are considered the first line therapy for acute flares and to manage chronic pain. This often times leads to a stigma of being "opiate seekers" or "frequent fliers". With this study, we wish to explore whether adding ketamine to standard acute opiate therapy (morphine or dilaudid) will decrease subsequent repeat doses of opiates while improving the patient's perception of pain. In addition, we will be exploring whether ketamine as an adjuvant therapy can help reduce hospital admissions for the management of acute sickle cell crisis pain.

  • Pain
  • Sickle Cell Disorder

Total execution time in seconds: 0.89048099517822